Your search returned 13 studies. (Get alerts for new studies):
- NVA237 BID Versus Placebo Twelve-week Efficacy Study
Conditions: Chronic Obstructive Pulmonary Disease
Location: Fremont, Nebraska
- Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Fremont, Nebraska
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Fremont, Nebraska
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Fremont, Nebraska
- Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Fremont, Nebraska
- CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
Conditions: Dupuytren's Contracture
Location: Norfolk, Nebraska
- Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Fremont, Nebraska
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Fremont, Nebraska
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of
Conditions: Measles, Mumps and Rubella Diseases
Location: Fremont, Nebraska
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Fremont, Nebraska
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Fremont, Nebraska
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Fremont, Nebraska
- A Global Phase 3 Safety Study of 120 Mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Conditions: Meningitis, Meningococcal
Location: Fremont, Nebraska
|